Caregiver with Patient
 

Bringing You the World's First

Patient-Friendly Catheter

Here at UroSense we rethink the catheter. Our data and experimental driven approach is aimed towards reducing catheter infection rates worldwide, reducing antibiotics costs. 

Our Mission

We are on a mission to
disrupt the urological space

We are UroSense, a recently-founded medical device  company based in the United Kingdom, with the  objective to innovate and redesign the current Foley  cathter 

The aim is to improve the striking UK catheter-associate unrinary infection (CAUTI) rates, with the ultimate goal being to also see improvements in global CAUTI rates.

A Problem Long Overdue

The most common healthcare associated infection worldwide

We have an issue, a life-threatening issue, a life-threatening issue. Right now, the medical field is succumbing to the detrimental yet preventable effects of catheter-associated urinary tract infectious (CAUTIs) The most common healthcare associate infection worldwide. Current catheters were design nearly 80 years ago, and haven't faced any significant change since then

In the UK, these infections can be seen occurring on a colossal scale, from within national hospitals to local care homes, creating a £100M economic burden on the NHS annually. Moreover, studies show that harm resulting from urinary catheters accounts for nearly 2000 deaths in the UK each year. Astonishing, right? The truth is, this isn't just a UK problem, it's a global problem. 

Awards

Our Partners 

Join us in creating a CAUTI free world

UroSense

Here at UroSense we rethink the catheter. Our data and experimental driven approach is aimed towards reducing catheter infection rates worldwide, reducing antibiotics costs. 

Get In Touch 

+7563851565

University College London

Gower Street

London WC1E 6BT, UK

Social Media

  • LinkedIn

©2021 by UroSense.